Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiomo is a private digital health and medical device company developing a wearable remote cardiac monitoring system for continuous heart health surveillance outside the hospital. Its offering combines a reusable ECG patch, connected biosensors, a mobile application, and a cloud-based analytics platform that uses proprietary algorithms and AI to detect arrhythmias and other early signs of cardiovascular deterioration. The system tracks ECG, heart rate, respiration rate, skin temperature, body position, activity, and related vital signals, and sends alerts to patients, caregivers, and clinicians in real time. Cardiomo appears focused on preventive cardiology, home-based monitoring, and telehealth-enabled care for patients with cardiovascular risk, seniors, and other populations needing continuous monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiomo.